These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

49 related articles for article (PubMed ID: 1847762)

  • 1. Synthesis and biological evaluation of 2,3,5-trimethyl-6-(3-pyridylmethyl)-1,4-benzoquinone (CV-6504), a dual inhibitor of TXA2 synthase and 5-lipoxygenase with scavenging activity of active oxygen species (AOS).
    Terao S; Ohkawa S; Terashita Z; Shibouta Y; Nishikawa K
    Adv Prostaglandin Thromboxane Leukot Res; 1991; 21A():173-6. PubMed ID: 1847762
    [No Abstract]   [Full Text] [Related]  

  • 2. Dual inhibitors of thromboxane A2 synthase and 5-lipoxygenase with scavenging activity of active oxygen species. Synthesis of a novel series of (3-pyridylmethyl)benzoquinone derivatives.
    Ohkawa S; Terao S; Terashita Z; Shibouta Y; Nishikawa K
    J Med Chem; 1991 Jan; 34(1):267-76. PubMed ID: 1992126
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Leukotrienes during rejection after canine pancreatic allotransplantation.
    Shimizu K; Izumi R; Horichi H; Yagi M; Hashimoto T; Watanabe T; Iyobe T; Iwasa K; Ii T; Fukushima W
    Transplant Proc; 1994 Aug; 26(4):2288-9. PubMed ID: 8066752
    [No Abstract]   [Full Text] [Related]  

  • 4. Structure-activity relationships of (E)-3-(1,4-benzoquinonyl)-2-[(3-pyridyl)-alkyl]-2-propenoic acid derivatives that inhibit both 5-lipoxygenase and thromboxane A2 synthetase.
    Hibi S; Okamoto Y; Tagami K; Numata H; Kobayashi N; Shinoda M; Kawahara T; Harada K; Miyamoto K; Yamatsu I
    J Med Chem; 1996 Aug; 39(16):3148-57. PubMed ID: 8759636
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Novel dual inhibitors of 5-lipoxygenase and thromboxane A2 synthetase: synthesis and structure-activity relationships of 3-pyridylmethyl-substituted 2-amino-6-hydroxybenzothiazole derivatives.
    Hibi S; Okamoto Y; Tagami K; Numata H; Kobayashi N; Shinoda M; Kawahara T; Murakami M; Oketani K; Inoue T
    J Med Chem; 1994 Sep; 37(19):3062-70. PubMed ID: 7932529
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Effect of a thromboxane synthetase inhibitor on eicosanoid synthesis and glomerular injury during acute unilateral glomerulonephritis in the rat.
    Cook HT; Cattell V; Smith J; Salmon JA; Moncada S
    Clin Nephrol; 1986 Oct; 26(4):195-202. PubMed ID: 3490944
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Reduction of 2,3,5-trimethyl-6-(3-pyridylmethyl)-1,4-benzoquinone by PB-3c cells and biological activity of its hydroquinone.
    Ohkawa S; Terao T; Murakami M; Matsumoto T; Goto G
    Chem Pharm Bull (Tokyo); 1991 Apr; 39(4):917-21. PubMed ID: 1893498
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Involvement of thromboxane A2, leukotrienes and free radicals in puromycin nephrosis in rats.
    Shibouta Y; Terashita Z; Imura Y; Shino A; Kawamura M; Ohtsuki K; Ohkawa S; Nishikawa K; Fujiwara Y
    Kidney Int; 1991 May; 39(5):920-9. PubMed ID: 2067208
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Blockade of cytosolic phospholipase A(2) and 5-lipoxygenase activation in neutrophils by a natural isoflavanquinone abruquinone A.
    Hsu MF; Chang LC; Chen SC; Kuo SC; Lee HY; Lu MC; Wang JP
    Eur J Pharmacol; 2008 Nov; 598(1-3):123-31. PubMed ID: 18834875
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Structure and activity relationships leading to the discovery of ICI D2138, a selective, potent and orally active inhibitor of 5-lipoxygenase.
    Crawley GC; Bird TG; Bruneau P; Dowell RI; Edwards PN; Foster SJ; Girodeau JM; McMillan RM; Walker ER; Waterson D
    J Lipid Mediat; 1993; 6(1-3):249-57. PubMed ID: 8395247
    [TBL] [Abstract][Full Text] [Related]  

  • 11. [Synthesis of prostaglandins (TXB2 and 6-keto-PGF1 alpha) during cardiopulmonary bypass].
    Arima T; Ohata M; Ishizuka K; Sakamoto T; Hori T
    Masui; 1986 Feb; 35(2):277-85. PubMed ID: 3754591
    [No Abstract]   [Full Text] [Related]  

  • 12. [Sodium ferulate is an inhibitor of thromboxane A2 synthetase].
    Wang Z; Gao YH; Huang RS; Zhu GQ
    Zhongguo Yao Li Xue Bao; 1988 Sep; 9(5):430-3. PubMed ID: 3218538
    [No Abstract]   [Full Text] [Related]  

  • 13. Development of dual-acting agents for thromboxane receptor antagonism and thromboxane synthase inhibition. 3. Synthesis and biological activities of oxazolecarboxamide-substituted omega-phenyl-omega-(3-pyridyl)alkenoic acid derivatives and related compounds.
    Takeuchi K; Kohn TJ; True TA; Mais DE; Wikel JH; Utterback BG; Wyss VL; Jakubowski JA
    J Med Chem; 1998 Dec; 41(27):5362-74. PubMed ID: 9876106
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Inhibition of 5-lipoxygenase: development of hydroxamic acids and hydroxyureas as potential therapeutic agents.
    Salmon JA; Jackson WP; Garland LG
    Adv Prostaglandin Thromboxane Leukot Res; 1991; 21A():109-12. PubMed ID: 1847758
    [No Abstract]   [Full Text] [Related]  

  • 15. Effects of flunixin meglumine, phenylbutazone and a selective thromboxane synthetase inhibitor (UK-38,485) on thromboxane and prostacyclin production in healthy horses.
    Hardee MM; Moore JN; Hardee GE
    Res Vet Sci; 1986 Mar; 40(2):152-6. PubMed ID: 3517992
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Effect of 5-lipoxygenase inhibitor on canine pancreatic allotransplantation.
    Horichi H; Izumi R; Shimizu K; Konishi K; Kitabayashi K; Watanabe T; Miyazaki I
    Transplant Proc; 1991 Feb; 23(1 Pt 2):1679-80. PubMed ID: 1846481
    [No Abstract]   [Full Text] [Related]  

  • 17. Thromboxane synthesis inhibition and renal allograft function.
    Anderson C; Jendrisak M; Brunt E; Tobimatsu M; Murphy M; Sicard G; Mangino M
    Transplant Proc; 1989 Feb; 21(1 Pt 1):1161-4. PubMed ID: 2650085
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Evaluation of the antiinflammatory activity of a dual cyclooxygenase-2 selective/5-lipoxygenase inhibitor, RWJ 63556, in a canine model of inflammation.
    Kirchner T; Argentieri DC; Barbone AG; Singer M; Steber M; Ansell J; Beers SA; Wachter MP; Wu W; Malloy E; Stewart A; Ritchie DM
    J Pharmacol Exp Ther; 1997 Aug; 282(2):1094-101. PubMed ID: 9262379
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Determination of leukotriene B4, 6-keto-prostaglandin F1 alpha and thromboxane B2 in peritoneal lavage fluid of sham-operated and adrenalectomized rats.
    Vincent JE; Zijlstra FJ
    Prostaglandins Leukot Essent Fatty Acids; 1988 Sep; 33(3):203-4. PubMed ID: 2847202
    [TBL] [Abstract][Full Text] [Related]  

  • 20. 5-Lipoxygenase inhibitors: synthesis and structure-activity relationships of a series of 1-aryl-2H,4H-tetrahydro-1,2,4-triazin-3-ones.
    Bhatia PA; Brooks CD; Basha A; Ratajczyk JD; Gunn BP; Bouska JB; Lanni C; Young PR; Bell RL; Carter GW
    J Med Chem; 1996 Sep; 39(20):3938-50. PubMed ID: 8831760
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 3.